{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:03:49Z","timestamp":1787022229903,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001465","name":"American Thoracic Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1378\/chest.11-0404","type":"journal-article","created":{"date-parts":[[2011,9,22]],"date-time":"2011-09-22T20:19:17Z","timestamp":1316722757000},"page":"20-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"title":["Race and Sex Differences in Response to Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"141","author":[{"given":"Nicole B.","family":"Gabler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Strom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold I.","family":"Palevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren B.","family":"Taichman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Kawut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1378\/chest.11-0404_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2006.11.012","article-title":"Epidemiology of pulmonary arterial hypertension","volume":"28","author":"Taichman","year":"2007","journal-title":"Clin Chest Med"},{"issue":"4","key":"10.1378\/chest.11-0404_bib2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.0887-378X.2004.00327.x","article-title":"Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages","volume":"82","author":"Kravitz","year":"2004","journal-title":"Milbank Q"},{"issue":"6","key":"10.1378\/chest.11-0404_bib3","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1378\/chest.08-2006","article-title":"Failure of medical therapy in pulmonary arterial hypertension. Is there an alternative diagnosis?","volume":"135","author":"Harch","year":"2009","journal-title":"Chest"},{"issue":"16","key":"10.1378\/chest.11-0404_bib4","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"McLaughlin","year":"2009","journal-title":"Circulation"},{"issue":"9147","key":"10.1378\/chest.11-0404_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(98)09423-9","article-title":"Endothelin antagonists","volume":"353","author":"Benigni","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1378\/chest.11-0404_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/0003-4819-114-6-464","article-title":"Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?","volume":"114","author":"Stewart","year":"1991","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1378\/chest.11-0404_bib7","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1378\/chest.120.5.1562","article-title":"Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension","volume":"120","author":"Rubens","year":"2001","journal-title":"Chest"},{"issue":"4 Pt 1","key":"10.1378\/chest.11-0404_bib8","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/0002-8703(92)90734-D","article-title":"Age- and sex-related variation of plasma endothelin-1 concentration in normal and hypertensive subjects","volume":"123","author":"Miyauchi","year":"1992","journal-title":"Am Heart J"},{"issue":"6","key":"10.1378\/chest.11-0404_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-118-6-199303150-00006","article-title":"Influence of sex hormones on plasma endothelin levels","volume":"118","author":"Polderman","year":"1993","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1378\/chest.11-0404_bib10","doi-asserted-by":"crossref","first-page":"R261","DOI":"10.1152\/ajpregu.00626.2009","article-title":"Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults","volume":"298","author":"Stauffer","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"10.1378\/chest.11-0404_bib11","first-page":"707","article-title":"Plasma endothelin-1 release during acute stress: role of ethnicity and sex","volume":"64","author":"Treiber","year":"2002","journal-title":"Psychosom Med"},{"issue":"25","key":"10.1378\/chest.11-0404_bib12","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1161\/01.CIR.0000130590.24107.D3","article-title":"Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients","volume":"109","author":"Campia","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"10.1378\/chest.11-0404_bib13","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"issue":"9288","key":"10.1378\/chest.11-0404_bib14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"issue":"23","key":"10.1378\/chest.11-0404_bib15","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Gali\u00e8","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"10.1378\/chest.11-0404_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1164\/rccm.200307-957OC","article-title":"Sitaxsentan therapy for pulmonary arterial hypertension","volume":"169","author":"Barst","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1378\/chest.11-0404_bib17","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2006.01.057","article-title":"Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan","volume":"47","author":"Barst","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1378\/chest.11-0404_bib18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1378\/chest.11-0404_bib19","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1161\/CIRCULATIONAHA.107.736785","article-title":"Does size matter? Clinical applications of scaling cardiac size and function for body size","volume":"117","author":"Dewey","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"10.1378\/chest.11-0404_bib20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/aje\/kwn071","article-title":"Use of multiple imputation in the epidemiologic literature","volume":"168","author":"Klebanoff","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1378\/chest.11-0404_bib21","doi-asserted-by":"crossref","first-page":"L435","DOI":"10.1152\/ajplung.00057.2010","article-title":"The estrogen paradox in pulmonary arterial hypertension [published retraction appears in Am J Physiol Lung Cell Mol Physiol. 2011;300(3):L508]","volume":"299","author":"Sakao","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"10","key":"10.1378\/chest.11-0404_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/2047-783X-14-10-433","article-title":"Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension","volume":"14","author":"Sweeney","year":"2009","journal-title":"Eur J Med Res"},{"issue":"3","key":"10.1378\/chest.11-0404_bib23","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1378\/chest.08-1758","article-title":"Determinants of right ventricular ejection fraction in pulmonary arterial hypertension","volume":"135","author":"Kawut","year":"2009","journal-title":"Chest"},{"issue":"2","key":"10.1378\/chest.11-0404_bib24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1378\/chest.11-0404_bib25","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/01.HYP.28.4.652","article-title":"Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension","volume":"28","author":"Ergul","year":"1996","journal-title":"Hypertension"},{"issue":"1","key":"10.1378\/chest.11-0404_bib26","first-page":"69","article-title":"Increased mortality in African Americans with idiopathic pulmonary arterial hypertension","volume":"100","author":"Davis","year":"2008","journal-title":"J Natl Med Assoc"},{"issue":"2","key":"10.1378\/chest.11-0404_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.amjcard.2004.09.006","article-title":"New predictors of outcome in idiopathic pulmonary arterial hypertension","volume":"95","author":"Kawut","year":"2005","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1378\/chest.11-0404_bib28","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1111\/j.1600-6143.2006.01480.x","article-title":"Racial and ethnic disparities in idiopathic pulmonary fibrosis: A UNOS\/OPTN database analysis","volume":"6","author":"Lederer","year":"2006","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1378\/chest.11-0404_bib29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1600-6143.2005.01205.x","article-title":"Racial and ethnic disparities in survival in lung transplant candidates with idiopathic pulmonary fibrosis","volume":"6","author":"Lederer","year":"2006","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1378\/chest.11-0404_bib30","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7326\/0003-4819-150-5-200903030-00007","article-title":"Factors associated with racial differences in myocardial infarction outcomes","volume":"150","author":"Spertus","year":"2009","journal-title":"Ann Intern Med"},{"issue":"9455","key":"10.1378\/chest.11-0404_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0140-6736(05)70156-2","article-title":"Treating individuals 3: from subgroups to individuals: general principles and the example of carotid endarterectomy","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"issue":"11","key":"10.1378\/chest.11-0404_bib32","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/oxfordjournals.aje.a009590","article-title":"Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm","volume":"148","author":"Ioannidis","year":"1998","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1378\/chest.11-0404_bib33","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jama.298.10.1209","article-title":"Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification","volume":"298","author":"Kent","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"10.1378\/chest.11-0404_bib34","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1377\/hlthaff.24.6.1571","article-title":"Reporting clinical trial results to inform providers, payers, and consumers","volume":"24","author":"Hayward","year":"2005","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"10.1378\/chest.11-0404_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccm.2006.11.005","article-title":"Surrogate end points in pulmonary arterial hypertension: assessing the response to therapy","volume":"28","author":"Snow","year":"2007","journal-title":"Clin Chest Med"},{"key":"10.1378\/chest.11-0404_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-5573-4-4","article-title":"Power for tests of interaction: effect of raising the type I error rate","volume":"4","author":"Marshall","year":"2007","journal-title":"Epidemiol Perspect Innov"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212600099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212600099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T13:19:12Z","timestamp":1668604752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369212600099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0012369212600099"],"URL":"https:\/\/doi.org\/10.1378\/chest.11-0404","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13489110.14866253","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.13489110.15114060","asserted-by":"object"}]},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Race and Sex Differences in Response to Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.11-0404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1378\/chest.11-2225","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}